SUNS - South North Development Monitor
     INDEX        ARCHIVE        SEARCH        FROM GATT TO THE WTO        ABOUT
SUNS # 9304 Friday 12 March 2021

Trade : Strong support for TRIPS waiver amidst opposition by Big Pharma (PRIV)
(D. Ravi Kanth, Geneva)
More than 100 countries have upped the stakes for text-based negotiations on the TRIPS waiver proposal that seeks to temporarily suspend certain provisions of the WTO's TRIPS Agreement in combating the COVID-19 pandemic, amidst attempts by Big Pharma to kill the waiver proposal, said people familiar with the development.

Opinion : Feminist leadership at the UN - gender equality within & without (PRIV)
(IPS, New York)
When the United Nations was founded in 1945, the principle of equality for all - regardless of sex, race, language, or religion - was enshrined in the organization's Charter.

Rights : Drug users often don't seek help as they fear legal repercussion (PRIV)
(IPS, Apia)
In the February 12th editorial on the issue of illicit drug use, the Samoa Observer stated that "... there is no data currently available to show that drug abuse including meth consumption levels in Samoa have reached crisis levels, which would warrant the government considering de-criminalizing drug use and consumption."

  About   Publisher: Third World Network, 131 Jalan Macalister, 10400 penang, malaysia
Editor emeritus: chakravarthi raghavan.
Editor: kanaga raja, rm c508, 8-14 Avenue de la Paix, ch-1211 geneva 10, switzerland; tel:(4122) 7344274, fax 7401672; email:
Advisory board: rajiv kumar chander, triyono wibowo
As a non-profit service, subscriptions are intended to cover or contribute to costs of operations. terms and special conditions: information available from publisher.


[c] 2013, SUNS - All rights reserved. May not be reproduced, reprinted or posted to any system or service without specific permission from SUNS. This limitation includes incorporation into a database, distribution via Usenet News, bulletin board systems, mailing lists, print media or broadcast. For information about reproduction or multi-user subscriptions please contact <>